102.645 articles found

Video-Based Quantitative Assessment of Facial Expressivity in the Follow-up of Parkinson’s Disease

Parga-Nájera HE, Rojas-Arce JL, Aguilar-Pérez LA, Morales-Sánchez IS, Jimenez-Angeles L.

· 2026-09-24

DOI: 10.20944/preprints202609.2168.v1

Gut Microbiome-Mediated Neuroprotective Effect of the Mediterranean Diet: A Narrative Review of Cognitive Aging, Alzheimer’s Disease, and Parkinson’s Disease

Kamalakar K, Akerele C, Lafont E, Koralnik L, Gilman C, Litran J, Lee J, Robinson-Papp J, Malaspina D.

Nutrients · 2026-09-24

Navigating PINK1 Parkinson's Disease: Narratives of Pacific Patients and Caregivers.

Fa'alau F, Kiadarbandsari A, Foroti M, Roxburgh R, Buchanan CM.

Parkinsons Dis · 2026-09-24

DOI: 10.1155/padi/4024943PMID: 42787988

Longitudinal characterization of biomechanical alterations in a Parkinson's disease mouse model using three-dimensional ground reaction forces.

Ning M, Li J, Yang S, Ye M, Fan Y, Dai Z.

Clin Park Relat Disord · 2026-09-24

DOI: 10.1016/j.prdoa.2026.100503PMID: 42836023

The clinical value of combined assessment of substantia nigra morphology and intracranial hemodynamics via transcranial ultrasound in the diagnosis and differentiation of Parkinson's disease.

Liang L, Cui Q.

Front Neurol · 2026-09-24

DOI: 10.3389/fneur.2026.1913166PMID: 42851415

AGMNet: an explainable gated multimodal framework integrating MRI heterogeneity and dopaminergic asymmetry for Parkinson's disease classification.

Abinaya TG, Sivashankari R.

Front Artif Intell · 2026-09-24

DOI: 10.3389/frai.2026.1849408PMID: 42851505

Comparison of automated white matter lesion segmentation approaches for use in large, multi-site data analyses in Parkinson's disease.

Al-Bachari S, Yoon SH, Emson P, Angell S, Cain J, Abraham A, Chughtai A, Sizer E, Barnes E, Al-Wardy M, Kannan S, Paul-Thaper R, Bright J, Owens-Walton C, McMillan CT, Klein JC, Griffanti L, Thomopoulos SI, Jahanshad N, Thompson PM, van der Werf YD, Vriend C, Parkes LM, Emsley HCA, Schrag A, Haroon HA.

Front Neurosci · 2026-09-24

DOI: 10.3389/fnins.2026.1904361PMID: 42852118

Enhancing the glymphatic system as a potential pathway to limit Parkinson disease progression.

Yan Z, Howitt J.

Expert Opin Ther Targets · 2026-09-24

DOI: 10.1080/14728222.2026.2738182PMID: 42767645

Reliability, Validity and Determinants of Self-Reported Autonomic Dysfunction in Prodromal and Established Parkinson's Disease.

Mahajan A, Karstens AJ, González DA.

Mov Disord Clin Pract · 2026-09-24

DOI: 10.1002/mdc3.70826PMID: 42779503

Digital Handwriting Reveals Motor Impairment, Dopaminergic Response, and Progression in Parkinson's Disease.

Díaz-Feliz L, Faundez-Zanuy M, Gennari A, Sánchez-Reyes A, Sanz-Cartagena P, Arbelo-González J, García-Cabezas MÁ, García-Ruiz P.

Mov Disord Clin Pract · 2026-09-24

DOI: 10.1002/mdc3.70835PMID: 42779527

Weight changes and physical activity in Parkinson's disease: converging markers of energy balance, disease progression, and lifestyle-based care.

Urso D, Logroscino G.

J Neural Transm (Vienna) · 2026-09-24

DOI: 10.1007/s00702-026-03297-8PMID: 42782348

Stress and Parkinson's disease: from dysfunctional detection to impaired handling: a narrative review.

Diederich NJ, Pauly C.

J Neural Transm (Vienna) · 2026-09-24

DOI: 10.1007/s00702-026-03267-0PMID: 42782353